Iontronic Tech Promises Hope in Slowing Malignant Brain Tumors by Lilu Anderson 20.06.2024 "Iontronic tech shows promise in slowing malignant brain tumor growth by continuously delivering low-dose drugs, bypassing the blood-brain barrier."
Day One Biopharma Expands to ADCs with $55M Drug Acquisition by Lilu Anderson 19.06.2024 "Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
U.S. IPO Weekly Recap: Biotech Leads Short Week by Mark Eisenberg 30.03.2024 Phase 1 biotech Boundless Bio raised $100 million at a $396 million market cap. Two IPOs are scheduled for the ...
Biotechnology Diversity: Driving Innovation #DiversityinBiotechnology by Lilu Anderson 19.02.2024 Diversity in biotechnology and venture capital is crucial for driving innovation and breakthroughs in healthcare, according to Dr. Stanley Lewis. ...
Revolutionizing Success: Diversity Boosts Biotech VC Funding by Lilu Anderson 19.02.2024 Efforts to diversify biotech venture capital funding could lead to innovation, breakthroughs in healthcare, and improved outcomes for minorities.
Researchers from Cleveland Clinic and IBM Unveil AI Strategy for Immunotherapy Targets by Lilu Anderson 23.01.2024 Cleveland Clinic and IBM join forces to advance immunotherapy research through AI, unlocking new targets for cancer therapy. #Immunotherapy #AI ...